Comparison of Serum Levels of Magnesium and Potassium in Stroke Patient and Healthy Controls

CVA (cerebrovascular accident) is the most common debilitating disease. Studies show that magnesium and potassium have significant neuroprotective effects. The aim of this study is evaluation of serum levels of potassium and magnesium in stroke patients. In this case study, 70 stroke patients were entered in following manner. For a patient, a questionnaire include: age, sex, and kind of stroke was provided and then, in which the serum levels of magnesium and potassium were entered. These levels were compared with those of control group (70 people) whose individuals were sexual and age wise identical and results from these were analyzed with statisticaltest, t-test. From 70 patients who were entered in this study, 39 (55.7%) individuals were male and 31 (44.3%) female. The mean age of case group was 72.1110.76. The mean serum level of magnesium and potassium in case group was 1.89) 0.25meq/L and 3.810.26 meq/L respectively and in control group was 1.95) 0.46 meq/L and 3.90.41 meq/L that showed the mean serum level of magnesium and potassium in CVA patients was lower than control group, and only about serum level K is significant (Pv=0.004) The serum level of magnesium and potassium in stroke patients is lower than control group.